Insider · CIK 0001784038
Fink Eric
Reports to the SEC for 1 company · SOUTH SAN FRANCISCO, CA
Transactions
25
Companies
1
Filings
7
CIK
0001784038
Forms 4 and 5
Insider transactions
| Date | Company | Value |
|---|---|---|
| 2021-05-10 | Global Blood Therapeutics, Inc.P Purchase | +$19K |
| 2021-03-01 | Global Blood Therapeutics, Inc.M Exercise/Conversion | — |
| 2021-03-01 | Global Blood Therapeutics, Inc.Restricted Stock UnitsM Exercise/Conversion | — |
| 2021-03-01 | Global Blood Therapeutics, Inc.Stock Option (Right to Buy)A Award | — |
| 2021-03-01 | Global Blood Therapeutics, Inc.Restricted Stock UnitsA Award | — |
| 2021-03-01 | Global Blood Therapeutics, Inc.F Tax Payment | −$38.2K |
| 2021-02-01 | Global Blood Therapeutics, Inc.M Exercise/Conversion | — |
| 2021-02-01 | Global Blood Therapeutics, Inc.F Tax Payment | −$46.9K |
| 2021-02-01 | Global Blood Therapeutics, Inc.A Award | +$13.7K |
| 2021-02-01 | Global Blood Therapeutics, Inc.Restricted Stock UnitsM Exercise/Conversion | — |
| 2020-10-05 | Global Blood Therapeutics, Inc.S Sale | −$272K |
| 2020-09-01 | Global Blood Therapeutics, Inc.Restricted Stock UnitsM Exercise/Conversion | — |
| 2020-09-01 | Global Blood Therapeutics, Inc.F Tax Payment | −$104K |
| 2020-09-01 | Global Blood Therapeutics, Inc.M Exercise/Conversion | — |
| 2020-08-05 | Global Blood Therapeutics, Inc.S Sale | −$66.6K |
| 2020-08-05 | Global Blood Therapeutics, Inc.S Sale | −$104K |
| 2020-08-01 | Global Blood Therapeutics, Inc.Restricted Stock UnitsM Exercise/Conversion | — |
| 2020-08-01 | Global Blood Therapeutics, Inc.M Exercise/Conversion | — |
| 2020-08-01 | Global Blood Therapeutics, Inc.F Tax Payment | −$55.9K |
| 2020-07-31 | Global Blood Therapeutics, Inc.A Award | +$14.6K |
| 2020-06-01 | Global Blood Therapeutics, Inc.Restricted Stock UnitsA Award | — |
| 2020-02-03 | Global Blood Therapeutics, Inc.Stock Option (Right to Buy)A Award | — |
| 2020-02-03 | Global Blood Therapeutics, Inc.Restricted Stock UnitsA Award | — |
| 2019-09-01 | Global Blood Therapeutics, Inc.Stock Option (Right to Buy)A Award | — |
| 2019-09-01 | Global Blood Therapeutics, Inc.Restricted Stock UnitsA Award | — |
Recent filings
- 4Fink Eric0000899243-21-019011SEC(opens sec.gov)
- 4Fink Eric0000899243-21-009591SEC(opens sec.gov)
- 4Fink Eric0000899243-21-004771SEC(opens sec.gov)
- 4Fink Eric0000899243-20-027726SEC(opens sec.gov)
- 4Fink Eric0000899243-20-024184SEC(opens sec.gov)
- 4Fink Eric0000899243-20-021756SEC(opens sec.gov)
- 4Fink Eric0000899243-20-021325SEC(opens sec.gov)
Companies
Address
C/O GLOBAL BLOOD THERAPEUTICS, INC. 171 OYSTER POINT BLVD., SUITE 300
SOUTH SAN FRANCISCO, CA, 94080